Sands Capital Life Sciences Pulse Fund III (DE), L.P. 13D and 13G filings for SpyGlass Pharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 11:36 am Purchase | 2026-02-06 | 13G | SPYGLASS PHARMA INC SGP | Sands Capital Life Sciences Pulse Fund III (DE), L.P. | 2,500,012 7.800% | 2,500,012 (New Position) | Filing |